Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:380-387
Published online before print December 18, 2008, doi: 10.1161/CIRCRESAHA.108.180695
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
104/3/380    most recent
CIRCRESAHA.108.180695v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, A. B.
Right arrow Articles by Edelman, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, A. B.
Right arrow Articles by Edelman, E. R.
Related Collections
Right arrow Remodeling
Right arrow Restenosis
Right arrow Genetically altered mice
Right arrow Smooth muscle proliferation and differentiation
Right arrow Type 2 diabetes
Right arrowRelated Article
(Circulation Research. 2009;104:380.)
© 2009 American Heart Association, Inc.


Integrative Physiology

Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice

Aaron B. Baker, Adam Groothuis, Michael Jonas, David S. Ettenson, Tarek Shazly, Eyal Zcharia, Israel Vlodavsky, Philip Seifert, Elazer R. Edelman

From the Harvard–Massachusetts Institute of Technology Division of Health Sciences and Technology (A.B.B., A.G., M.J., D.S.E., T.S., P.S., E.R.E.), Massachusetts Institute of Technology, Cambridge; Cardiovascular Division (M.J., E.R.E.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and Cancer and Vascular Biology Research Center (E.Z., I.V.), Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Correspondence to Aaron B. Baker, Massachusetts Institute of Technology, 77 Massachusetts Ave, Building E25, Room 442, Cambridge, MA 02139. E-mail abbaker{at}mit.edu

Heparan sulfate proteoglycans (HSPGs) are potent regulators of vascular remodeling and repair. Heparanase is the major enzyme capable of degrading heparan sulfate in mammalian cells. Here we examined the role of heparanase in controlling arterial structure, mechanics, and remodeling. In vitro studies supported that heparanase expression in endothelial cells serves as a negative regulator of endothelial inhibition of vascular smooth muscle cell (vSMC) proliferation. Arterial structure and remodeling to injury were also modified by heparanase expression. Transgenic mice overexpressing heparanase had increased arterial thickness, cellular density, and mechanical compliance. Endovascular stenting studies in Zucker rats demonstrated increased heparanase expression in the neointima of obese, hyperlipidemic rats in comparison to lean rats. The extent of heparanase expression within the neointima strongly correlated with the neointimal thickness following injury. To test the effects of heparanase overexpression on arterial repair, we developed a novel murine model of stent injury using small diameter self-expanding stents. Using this model, we found that increased neointimal formation and macrophage recruitment occurs in transgenic mice overexpressing heparanase. Taken together, these results support a role for heparanase in the regulation of arterial structure, mechanics, and repair.


Key Words: heparanase • vascular remodeling • restenosis • stenting • arterial compliance


Related Article:

Getting Neointimal: The Emergence of Heparanase Into the Vascular Matrix
Christian Aalkjaer and Donna Briggs Boedtkjer
Circ. Res. 2009 104: 277-279. [Extract] [Full Text] [PDF]